Last Updated: November 8, 2017
Filed under:
Print Friendly, PDF & Email

By Blair Childs, senior vice president of public affairs, Premier Premier and its members commend the FDA for taking important steps through draft guidance to stem drug manufacturers’ abuse of the Risk Evaluation and Mitigation Strategy (REMS) – a process that (more…)

Last Updated: June 14, 2017
Filed under:
Print Friendly, PDF & Email

Respondents report increasing drug costs, greater use of specialty drugs as sources of higher pharmaceutical spend; anticipate pharmaceutical spend to steadily increase over next five years CHARLOTTE, N.C. – A new Premier Inc. (NASDAQ: PINC) survey finds drug spending has (more…)

Last Updated: May 30, 2017
Filed under:
Print Friendly, PDF & Email

Modern Healthcare: Hospitals use the sterile form of baking soda—a sodium bicarbonate solution, which has baking soda as its base ingredient—in vital situations including heart surgery and other emergency events when a patient’s blood is too acidic, which can lead to (more…)

Last Updated: May 18, 2017
Filed under:
Print Friendly, PDF & Email

Today, Premier and 9 other healthcare groups sent a letter to the FDA in response to the agency’s draft guidance on obtaining an interchangeability designation for a biosimilar drug. In the letter, Premier expressed support of the draft guidance, but (more…)